San Diego Bleeding Esophageal Varices Study
Completed · Not applicable
Conditions studied: Survival and Control of Bleeding
In brief
In unselected cirrhotic patients with bleeding esophageal varices to compare the influence on mortality rate, duration of life, quality of life, and economic costs of treatment of: * Emergency portacaval shunt, and * Emergency and long-term endoscopic sclerotherapy.
Key facts
- Study ID
- NCT00690027
- Run by
- University of California, San Diego
- People needed
- 211
- Starts
- 1988-04-01
- Expected to finish
- 2005-12-01
- Last updated by the study team
- 2008-06-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients with UGI bleeding (blood in the esophagus, stomach, or duodenum) who enter the emergency room or develop bleeding while in the hospital or are transferred from nearby hospitals and are suspected of having cirrhosis and BEV will be eligible for consideration (all comers).
- Those who are shown to have the findings of cirrhosis and esophageal varices that:
- Are seen to be actively bleeding;
- Have an adherent clot;
- Have no other associated lesion that could reasonably account for bleeding of that magnitude (such as large gastric or duodenal varices, GU, DU, etc)
- Require 2 or more units of blood transfusion, will be included in the study.
You may not qualify if…
- None
Where it is running
- 200 West Arbor Drive — San Diego, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.